Avantogen Oncology Company Profile

05:33 EST 18th January 2019 | BioPortfolio

Avantogen Limited is a drug development Company whose current activities are focused on its three product candidates, namely, RP101 (a potential therapy for pancreatic cancer), GPI-0100 (vaccine adjuvants) and Pentrys™ (cancer vaccine). The Company is currently overseeing Phase II human testing of RP101 in Germany, Phase I human testing of GPI-0100 in the U.S and Phase II human testing of the Pentrys™ cancer vaccine in Australia. In addition, licensing partnerships are being sought by the Directors in respect of the Company's product line of medical nutritionals, Revisys™. Whilst the Company was capable of continuing its product development activities for each of these programs, the Directors decided to restructure both of the Vaccine and Oncology Businesses which would allow the Company to further streamline its activities whilst retaining the significant potential of each product candidate. Merging these products with Hawaii Biotech, Inc and Innovate Oncology, Inc has opened new business potentials leveraging upon the significant experience and expertise these companies have in these respective fields. The final signing of both these formal agreements took place in May 2006.


2121 Avenue of the Stars, Suite 2550
Los Angeles
United States of America


Phone: (310) 552-2001
Fax: (310) 772-0538

News Articles [471 Associated News Articles listed on BioPortfolio]

US FDA approves Catalent’s collaborative oncology treatment

Oncology drug Copiktra was developed during a multi-year collaboration between Catalent Pharma and Verastem Oncology.

ESMO Immuno-Oncology Congress: where the community of stakeholders meets

(European Society for Medical Oncology) The European Society for Medical Oncology (ESMO), the leading professional organisation for medical oncology, is pleased to announce the ESMO Immuno-Oncology 20...

bluebird bio and Gritstone Oncology to Collaborate

bluebird bio (NASDAQ:BLUE) and Gritstone Oncology announced Thursday (August 23) in a joint press release the two will research, develop and commercialize oncology cell therapy treatments. The post bl...

Avacta Group event to focus on immuno-oncology advances and role of its technology in the emerging field of science

Dr Josep Tabernero, President of the European Society for Medical Oncology and Head of the Val d'Hebron Institute of Oncology, Barcelona, will give the plenary presentation

Eli Lilly Deepens Its Oncology Offerings with an $8 Billion Acquisition of Loxo Oncology

Eli Lilly and Company announced it was buying Loxo Oncology for $235 per share in cash, which comes to about $8 billion. The acquisition adds a lot of weight to Lilly’s oncology efforts.

The Integrative Oncology Scholars Program: Indoctrinating the next generation of “integrative oncology” believers

"Integrative oncology" involves "integrating" pseudoscience, mysticism, and quackery with science-based oncology and co-opting science-based lifestyle modalities as "alternative" in order to provide c...

Men and women are different: Why medical oncology needs to restate the obvious

(European Society for Medical Oncology) Gender-based approaches to studying and treating disease have remained largely unexplored in medical oncology, despite the field's growing interest in precision...

ESMO Immuno-Oncology Congress showcases new technologies set to improve cancer treatment

(European Society for Medical Oncology) Innovation in immuno-oncology is exploding and new technologies that are set to benefit many patients with cancer are being showcased in the highly diverse arra...

PubMed Articles [1239 Associated PubMed Articles listed on BioPortfolio]

Share of Oncology Versus Nononcology Spending in Episodes Defined by the Centers for Medicare & Medicaid Services Oncology Care Model.

Performance-based payments to oncology providers participating in the Centers for Medicare & Medicaid Services (CMS) Oncology Care Model (OCM) are based, in part, on overall spending in 6-month episod...

Burnout and Resiliency in Canadian Oncology Residents: a Nationwide Resident and Program Director Survey.

To measure burnout rates and resiliency scores in Canadian Oncology residents and to advance the knowledge regarding resiliency and wellness training in Canadian Oncology residency programs.

Development of a Virtual Radiation Oncology Clinic for training and simulation of errors in the radiation oncology workflow.

Integrative Oncology Scholars Program: A Model for Integrative Oncology Education.

Oncology providers are often confronted by patients who use complementary or alternative therapies, but have limited knowledge or confidence on how to advise patients on appropriate use. Despite this,...

The State of Oncology Practice in America, 2018: Results of the ASCO Practice Census Survey.

To describe the US hematology and medical oncology practice landscape and to report findings of the sixth annual ASCO Oncology Practice Census survey.

Clinical Trials [576 Associated Clinical Trials listed on BioPortfolio]

Examining Patient Preferences About the IBM Watson Oncology Clinical Decision Support System

The purpose of this study is to learn what cancer patients think about IBM Watson Oncology. IBM Watson Oncology is a computer program designed to help inform oncologists about the best che...

Support of the Sexual Health in Oncology

Implementation of sexual health support program in oncology department. This program is organized in 3 axes. One is to inform the side effects of treatment on sexual health. There is a co...

Clinical Concordance Study Between Watson for Oncology and Clinician Practice

At present, Watson for Oncology has been applied in 14 countries worldwide, including China, the United States, Holland, Thailand, India, Korea, Poland, Slovakia and Bangladesh. In a doubl...

Osteopathic Manipulative Treatment in Oncology Patients' Management

The aim of present study was to study the osteopathic manipulative effects on pain relief and quality of life improvement on hospitalized oncology geriatric patients. A non-randomized comp...

Hospital Based Registry of Childhood Cancer in Pediatric Oncology Units in French Speaking Africa

The ultimate aim of this registry is to collect precise information concerning the children coming to oncology units working with the French African Oncology Group. This data will help to ...

Companies [749 Associated Companies listed on BioPortfolio]

Avantogen Oncology

Avantogen Limited is a drug development Company whose current activities are focused on its three product candidates, namely, RP101 (a potential therapy for pancreatic cancer), GPI-0100 (vaccine adjuv...

Takeda Oncology

Takeda Oncology, headquartered in Cambridge, MA, delivers novel medicines to patients with cancer worldwide through its commitment to science, breakthrough innovation and passion ...


OncLive is the official website for Intellisphere’s Oncology Specialty Group, which publishes Oncology & Biotech News, OncologyLive, Oncology Nursing News, and Contemporary O...

Cold Spring Publishing, LLC

Cold Spring Publishing, LLC, (CSP) is a medical publishing company whose principals have more than 50 years of combined publishing experience, with a specific focus in oncology. CSP publishes JNCCN --...

Michiana Hematology-Oncology,P.C.

Michiana Hematology-Oncology,P.C. is the premier provider of medical oncology, gynecologic oncology and adult hematology services in North-Central Indiana and Southwestern Lower Michigan.Michiana Hema...

More Information about "Avantogen Oncology" on BioPortfolio

We have published hundreds of Avantogen Oncology news stories on BioPortfolio along with dozens of Avantogen Oncology Clinical Trials and PubMed Articles about Avantogen Oncology for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Avantogen Oncology Companies in our database. You can also find out about relevant Avantogen Oncology Drugs and Medications on this site too.

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pancreatitis Acute pancreatitis is inflammation of the pancreas caused by the release of activated pancreatic enzymes. Common triggers are biliary tract disease and chronic heavy alcohol intake.  Diagnosis is based on clinical presentation...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Corporate Database Quicklinks

Searches Linking to this Company Record